| Schambeau Dental Care, P.c. | |
|
6260 Park South Dr Suite 101 Bessemer AL 35022-5655 | |
| (205) 428-2205 | |
| Not Available |
| Full Name | Schambeau Dental Care, P.c. |
|---|---|
| Speciality | Dentist |
| Location | 6260 Park South Dr, Bessemer, Alabama |
| Authorized Official Name and Position | Kevin Mcgowin Schambeau (PRESIDENT) |
| Authorized Official Contact | 2054282205 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Schambeau Dental Care, P.c. 6260 Park South Dr Suite 101 Bessemer AL 35022-5655 Ph: (205) 428-2205 | Schambeau Dental Care, P.c. 6260 Park South Dr Suite 101 Bessemer AL 35022-5655 Ph: (205) 428-2205 |
| NPI Number | 1487916789 |
|---|---|
| Provider Enumeration Date | 06/12/2012 |
| Last Update Date | 06/12/2012 |
| Medicare PECOS PAC ID | 0244494722 |
|---|---|
| Medicare Enrollment ID | O20120613000339 |
News Archive
In a study of 1,964 patients with multiple sclerosis (MS) led by researchers at the NYU Langone Multiple Sclerosis Comprehensive Care Center, extending the dose of natalizumab from 4 weeks up to 8 weeks was shown to be well-tolerated and effective in patients, and resulted in no cases of the potentially fatal side effect progressive multifocal leukoencephalopathy (PML).
Just months after receiving FDA approval, natalizumab, a medication for the treatment of multiple sclerosis (MS) and other inflammatory disorders, was voluntarily withdrawn by its manufacturers after three patients developed a brain infection known as Progressive Multifocal Leukoencephalopathy (PML).
One of the biggest research trials carried out in GP surgeries has confirmed that those with specialist cardiac nurse clinics can help to improve patients' lives.
As the World Bank meetings begin, a new study shows that investments in adolescent health and wellbeing are some of the best that can be made towards achieving the SDGs
On orders from Congress, Medicare is easing up on its annual readmission penalties on hundreds of hospitals serving the most low-income residents, records released last week show.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487916789 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 4737 (Alabama) | Primary |
| Provider Name | Kevin M Schambeau |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1508803735 PECOS PAC ID: 5799949277 Enrollment ID: I20120614000015 |
News Archive
In a study of 1,964 patients with multiple sclerosis (MS) led by researchers at the NYU Langone Multiple Sclerosis Comprehensive Care Center, extending the dose of natalizumab from 4 weeks up to 8 weeks was shown to be well-tolerated and effective in patients, and resulted in no cases of the potentially fatal side effect progressive multifocal leukoencephalopathy (PML).
Just months after receiving FDA approval, natalizumab, a medication for the treatment of multiple sclerosis (MS) and other inflammatory disorders, was voluntarily withdrawn by its manufacturers after three patients developed a brain infection known as Progressive Multifocal Leukoencephalopathy (PML).
One of the biggest research trials carried out in GP surgeries has confirmed that those with specialist cardiac nurse clinics can help to improve patients' lives.
As the World Bank meetings begin, a new study shows that investments in adolescent health and wellbeing are some of the best that can be made towards achieving the SDGs
On orders from Congress, Medicare is easing up on its annual readmission penalties on hundreds of hospitals serving the most low-income residents, records released last week show.
› Verified 4 days ago
News Archive
In a study of 1,964 patients with multiple sclerosis (MS) led by researchers at the NYU Langone Multiple Sclerosis Comprehensive Care Center, extending the dose of natalizumab from 4 weeks up to 8 weeks was shown to be well-tolerated and effective in patients, and resulted in no cases of the potentially fatal side effect progressive multifocal leukoencephalopathy (PML).
Just months after receiving FDA approval, natalizumab, a medication for the treatment of multiple sclerosis (MS) and other inflammatory disorders, was voluntarily withdrawn by its manufacturers after three patients developed a brain infection known as Progressive Multifocal Leukoencephalopathy (PML).
One of the biggest research trials carried out in GP surgeries has confirmed that those with specialist cardiac nurse clinics can help to improve patients' lives.
As the World Bank meetings begin, a new study shows that investments in adolescent health and wellbeing are some of the best that can be made towards achieving the SDGs
On orders from Congress, Medicare is easing up on its annual readmission penalties on hundreds of hospitals serving the most low-income residents, records released last week show.
› Verified 4 days ago
Pediatric Smiles Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 5751 Pocahontas Road, Suite B, Bessemer, AL 35022 Phone: 205-451-7029 | |
Mccalla Dental Dental Clinic Medicare: Medicare Enrolled Practice Location: 5751 Pocahontas Road, Suite A, Bessemer, AL 35022 Phone: 205-477-4242 Fax: 205-477-4243 | |
Pitner Family Dentistry Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 895 Memorial Dr, Bessemer, AL 35022 Phone: 205-426-2644 Fax: 205-424-8778 | |
Mission Dental Mobile Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1700 6th Ave N, Bessemer, AL 35020 Phone: 205-434-2031 | |
Dorsett Dental Care, Llc Dental Clinic Medicare: Medicare Enrolled Practice Location: 4000 Pine Ln Se, Bessemer, AL 35022 Phone: 205-882-8060 Fax: 205-539-1168 | |
Hueytown Family Dentistry, Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 3098 Allison Bonnett Memorial Dr, Bessemer, AL 35023 Phone: 205-491-2161 Fax: 205-491-2198 |